-
Detailed Analysis Generate Full Report Add to Watchlist
Values as of: 2019-10-16
Values as of: 2019-10-16
The investment seeks daily investment results, before fees and expenses, that correspond to two times (2x) the daily performance of the Dow Jones U.S. Health CareSM Index. The fund invests in securities and derivatives that ProShare Advisors believes, in combination, should have similar daily return characteristics as two times (2x) the daily return of the index. The index measures the performance of the healthcare sector of the U.S. equity market. Component companies include, among others, health care providers, biotechnology companies, medical supplies, advanced medical devices and pharmaceuticals. The fund is non-diversified.
Company Website : www.proshares.com
Currency: USD
Country : USA
Inception Date: 30/01/2007
Primary Benchmark: DJ US Health Care TR USD
Primary Index: S&P 500 TR USD
Gross Expense Ratio: 1.06%
Management Expense Ratio: 0.95 %
N/A
N/A
N/A
N/A
Symbol | Name | Mer | Price(Change) | Market Cap |
---|---|---|---|---|
SOJE | SOJE | 0.00 % |
-0.26 (-1.27%) |
USD 65.72B |
ITDC | Ishares Lifepath Target Date 2.. | 0.00 % |
+0.02 (+0.07%) |
USD 36.86B |
JEPI | JPMorgan Equity Premium Income.. | 0.00 % |
+0.09 (+0.16%) |
USD 32.78B |
LCR | Leuthold Core ETF | 0.00 % |
+0.03 (+0.10%) |
USD 32.52B |
DTB | DTB | 0.00 % |
+0.01 (+0.05%) |
USD 26.58B |
DFAC | Dimensional U.S. Core Equity 2.. | 0.00 % |
+0.08 (+0.25%) |
USD 26.11B |
JPST | JPMorgan Ultra-Short Income ET.. | 0.00 % |
-0.01 (-0.02%) |
USD 22.47B |
SGOV | iShares® 0-3 Month Treasury B.. | 0.00 % |
+0.01 (+0.01%) |
USD 18.58B |
TSPA | T. Rowe Price US Equity Resear.. | 0.00 % |
+0.06 (+0.18%) |
USD 16.23B |
DFUV | Dimensional US Marketwide Valu.. | 0.00 % |
+0.20 (+0.49%) |
USD 10.15B |
Symbol | Name | Weight | Mer | Price(Change) | Market Cap |
---|---|---|---|---|---|
KGHG | 4.13 % | 0.00 % |
N/A |
N/A | |
ESCEUA:SW | UBS(Lux)Fund Solutions .. | 1.30 % | 0.00 % |
N/A |
USD 0.14B |
CSEMUS:SW | iShares VII PLC - iShares.. | 1.29 % | 0.00 % |
N/A |
USD 0.71B |
MMS:LSE | Lyxor Index Fund - Lyxor .. | 1.24 % | 0.00 % |
N/A |
USD 0.29B |
SMCX:SW | SPDR® MSCI Europe Small .. | 0.51 % | 0.00 % |
-0.10 (-0.03%) |
USD 0.25B |
EUSC | WisdomTree Europe Hedged .. | 0.00 % | 0.58 % |
+0.01 (+-0.03%) |
USD 0.04B |
IEUS | iShares MSCI Europe Small.. | 0.00 % | 0.40 % |
-0.11 (-0.03%) |
USD 0.12B |
CES1:LSE | iShares MSCI EMU Small Ca.. | 0.00 % | 0.00 % |
+12.50 (+-0.03%) |
USD 0.71B |
SCZ | iShares MSCI EAFE Small-C.. | 0.00 % | 0.39 % |
-0.25 (-0.03%) |
USD 9.99B |
UB69:LSE | UBS MSCI EMU Small Cap UC.. | 0.00 % | 0.00 % |
+2.00 (+-0.03%) |
USD 0.10B |
XXSC:LSE | db x-trackers MSCI Europe.. | 0.00 % | 0.00 % |
+9.25 (+-0.03%) |
USD 1.07B |
MMS:PA | Lyxor Index Fund - Lyxor .. | 0.00 % | 0.00 % |
+1.61 (+-0.03%) |
USD 0.29B |
SMC:PA | SPDR MSCI Europe Small Ca.. | 0.00 % | 0.00 % |
+1.15 (+-0.03%) |
USD 0.23B |
LGWU:F | Lyxor Index Fund - Lyxor .. | 0.00 % | 0.00 % |
+0.50 (+-0.03%) |
USD 0.29B |
SXRJ:F | iShares VII Public Limite.. | 0.00 % | 0.00 % |
+0.40 (+-0.03%) |
USD 0.74B |
UEFD:F | UBS (Lux) Fund Solutions .. | 0.00 % | 0.00 % |
+0.14 (+-0.03%) |
USD 0.14B |
ZPRX:F | SSgA SPDR ETFs Europe II .. | 0.00 % | 0.00 % |
+0.03 (+-0.03%) |
USD 0.16B |
LGWU:XETRA | Lyxor Index Fund - Lyxor .. | 0.00 % | 0.00 % |
+0.70 (+-0.03%) |
USD 0.29B |
SXRJ:XETRA | iShares MSCI EMU Small Ca.. | 0.00 % | 0.00 % |
+0.50 (+-0.03%) |
USD 0.71B |
UEFD:XETRA | UBS(Lux)Fund Solutions .. | 0.00 % | 0.00 % |
+0.42 (+-0.03%) |
USD 0.10B |
ZPRX:XETRA | SPDR® MSCI Europe Small .. | 0.00 % | 0.00 % |
+0.24 (+-0.03%) |
USD 0.16B |
1388:TSE | 0.00 % | 0.00 % |
N/A |
N/A |
Market Performance vs. Industry/Classification (Others) | Market Performance vs. Exchange (NYSE Arca) | ||||||
Value | Sector Median | Percentile Rank | Grade | Market Median | Percentile Rank | Grade | |
YTD | |||||||
Capital Gain | 10.68% | 51% | F | 48% | F | ||
Dividend Return | 0.23% | 3% | F | 2% | F | ||
Total Return | 10.91% | 45% | F | 42% | F | ||
Trailing 12 Months | |||||||
Capital Gain | -8.58% | 17% | F | 29% | F | ||
Dividend Return | 0.30% | 3% | F | 3% | F | ||
Total Return | -8.28% | 16% | F | 27% | F | ||
Trailing 5 Years | |||||||
Capital Gain | 110.59% | 95% | A | 90% | A- | ||
Dividend Return | 2.74% | 15% | F | 10% | F | ||
Total Return | 113.33% | 95% | A | 89% | A- | ||
Average Annual (5 Year Horizon) | |||||||
Capital Gain | 12.10% | 93% | A | 84% | B | ||
Dividend Return | 12.47% | 93% | A | 80% | B- | ||
Total Return | 0.38% | 15% | F | 10% | F | ||
Risk Return Profile | |||||||
Volatility (Standard Deviation) | 18.86% | 20% | F | 40% | F | ||
Risk Adjusted Return | 66.14% | 70% | C- | 73% | C | ||
Market Capitalization | 0.07B | 51% | F | 24% | F |
Target Price Action | Rating Action | Analyst | Rating | Price | Date |
---|
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
The stock has outperformed its sector peers on average annual dividend returns basis in the past 5 years (for a hold period of at least 12 months) and is in the top quartile. This can be a good buy, especially if it is outperforming on total return basis , for investors seeking high income yields.
The stock is trading high compared to its peers on a price to earning basis and is above the sector median.
The company has under performed its peers on annual average total returns in the past 5 years.
The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.